Los puntos clave no están disponibles para este artículo en este momento.
Large clinical trials assessing treatments to reduce cardiovascular disease risk, such as SPRINT, can enroll heterogeneous populations of older adults, including the frail elderly, comparable with general population cohorts.
Pajewski et al. (Mon,) studied this question.